PersonGen Anke Cellular Therapeutice Co,Ltd.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia2 trials
• Childhood cancers1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Early phase 11 trial
• Phase 11 trial

Status

• Not yet recruiting2 trials
• Recruiting1 trial

Lead sponsor

• PersonGen BioTherapeutics (Suzhou) Co., Ltd.3 trials

Running trials

• Not yet recruiting

  Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

  NCT07623681· Phase 1· PersonGen BioTherapeutics (Suzhou) Co., Ltd.· Source

  Contact: Huimin Meng, Doctor

• Recruiting

  Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

  NCT07312630· Early phase 1· PersonGen BioTherapeutics (Suzhou) Co., Ltd.· Source

  Contact: Huimin Meng PersonGen.Anke Cellular Therapeutice Co., Ltd., Doctor

• Not yet recruiting

  Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

  NCT06871644· PersonGen BioTherapeutics (Suzhou) Co., Ltd.· Source

  Contact: Huimin Meng, doctor

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia2 recruiting
• Childhood cancers1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting